TCT-124 Safety and Feasibility of a Novel, Second Generation Robotic-Assisted System for Percutaneous Coronary Intervention: First-in-Human Report

Smitson, Christopher; Ang, Lawrence; Reeves, Ryan; Patel, Mitul; Mahmud, Ehtisham

doi:10.1016/j.jacc.2017.09.183

Cited by 29 publications

(34 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Robotic Technical Success was 91.7% (defined as clinical success and completion of the PCI procedure entirely robotically or with partial manual assistance), the rate of manual assistance was 11.1%, and the rate of manual conversion was 7.4%. Other studies have reported similar findings on the utility of R-PCI for treating complex CAD [7].…”

Section: Discussionsupporting

confidence: 71%

“…Since R-PCI eliminates the need for the interventionalist to wear heavy, lead-lined protective garments, it presumably ameliorates the risk of orthopedic injuries known to occur from repeated wearing of such garments [5]. In addition, recent software advances in the CorPath GRX robotic system have increased the accuracy and precision of measuring lesion size, stent length, and stent placement, as well as enhanced close-up viewing of angiographic images [4], [6], [7]. Remote robotic-assisted surgical procedures are also being increasingly employed in urology as well as in general surgical patients [8], [9].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience

2019

View full text Add to dashboard Cite

BackgroundRobotic-assisted percutaneous coronary intervention (R-PCI) has been successfully employed in the United States since 2011. Performing R-PCI from a remote location has never been reported but if feasible would extend availability of treatment to many patients with coronary artery disease (CAD) who would otherwise go without.ObjectiveTo assess the feasibility of remote tele-R-PCI with the operator 20 miles away from the patients.MethodsFive patients with single, type A coronary artery lesions treatable by PCI consented to participate. The primary endpoint was procedural success with no major adverse cardiac events (MACE) before discharge. Procedural success was defined as achieving < 10% diametric stenosis of the occluded target vessel utilizing tele-R-PCI balloon angioplasty and stent deployment (CorPath GRX®, Corindus Vascular Robotics, USA) without converting to in-lab manual PCI by an on-site standby team. Procedural, angiographic, and safety data were collected as were questionnaire scores from the remote operator evaluating the robot-network composite, image clarity, and overall confidence in the procedure.ResultsThe primary endpoint was achieved in 100% of patients. No procedural complications or adverse events occurred, and all patients were discharged the following day without MACE. The operator scores were favorable with the operators rating the procedure as equivalent to an in-lab procedure.ConclusionsPerforming long distance tele-R-PCI in patients with CAD is feasible with predictably successful outcomes if reliable network connectivity and local cardiac catheterization facilities are available.

show abstract

Section: Discussionsupporting

confidence: 71%

Section: Introductionmentioning

confidence: 99%

Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience

2019

View full text Add to dashboard Cite

show abstract

“…Robot-assisted coronary interventions have recently been developed as an alternative to reduce the reliance on manual operation, [214][215][216][217][218][219][220][221][222][223][224] potentially reducing damage from radiation exposure. 225 Clinical studies have demonstrated the safety and efficacy of the robotic system, which has already been approved for routine application in the US and the European Union.…”

Section: Robotic Angioplastymentioning

confidence: 99%

Guidelines os the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019

Lopes¹,

Oliveira²,

Ribeiro³

et al. 2019

Arquivos Brasileiros De Cardiologia

View full text Add to dashboard Cite

show abstract

“…109,110 The remote image-guided magnetic catheter guidance system has been used in ablation operation for the treatment of AF 111,112 and tachycardia. [113][114][115] Robotic-assisted catheter technology has also been widely used in mitral valve repair, 116,117 and robotics have been used in minimally invasive surgery to treat coronary artery stenosis 118,119 or to assist in navigation in thickened hypertrophic obstructive cardiomyopathy with septum myectomy, 120 which is associated with sudden cardiac death syndrome.…”

Section: Application Of Nanotechnology In Cardiac and Cardiothoracic mentioning

confidence: 99%

Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases

Li¹,

Liang²,

Xiao³

et al. 2018

IJN

View full text Add to dashboard Cite

Cardiovascular diseases (CVDs) are one of the most important causes of mortality and affecting the health status of patients. At the same time, CVDs cause a huge health and economic burden to the whole world. Although a variety of therapeutic drugs and measures have been produced to delay the progress of the disease and improve the quality of life of patients, most of the traditional therapeutic strategies can only cure the symptoms and cannot repair or regenerate the damaged ischemic myocardium. In addition, they may bring some unpleasant side effects. Therefore, it is vital to find and explore new technologies and drugs to solve the shortcomings of conventional treatments. Nanotechnology is a new way of using and manipulating the matter at the molecular scale, whose functional organization is measured in nanometers. Because nanoscale phenomena play an important role in cell signal transduction, enzyme action and cell cycle, nanotechnology is closely related to medical research. The application of nanotechnology in the field of medicine provides an alternative and novel direction for the treatment of CVDs, and shows excellent performance in the field of targeted drug therapy and the development of biomaterials. This review will briefly introduce the latest applications of nanotechnology in the diagnosis and treatment of common CVDs.

show abstract

TCT-124 Safety and Feasibility of a Novel, Second Generation Robotic-Assisted System for Percutaneous Coronary Intervention: First-in-Human Report

Cited by 29 publications

References 0 publications

Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience

Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience

Guidelines os the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019

Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases

Contact Info

Product

Resources

About